Cargando…
Gaining Perspective on mRNA COVID-19 Vaccination Risk
Autor principal: | Heymann, Warren R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299837/ https://www.ncbi.nlm.nih.gov/pubmed/37385451 http://dx.doi.org/10.1016/j.jaad.2023.06.034 |
Ejemplares similares
-
COVID-19 mRNA Vaccination
por: Vered, Livneh, et al.
Publicado: (2022) -
COVID-19 mRNA vaccines
por: Huang, Qingrui, et al.
Publicado: (2021) -
Myocarditis following COVID‐19 mRNA (mRNA‐1273) vaccination
por: Chellapandian, Suresh Babu, et al.
Publicado: (2022) -
COVID‐19 mRNA vaccines and myopericarditis
por: Gnanenthiran, Sonali R., et al.
Publicado: (2022) -
COVID-19 mRNA Vaccine and Myocarditis
por: Singh, Balraj, et al.
Publicado: (2021)